
Biofrontera AG BFRA
Biofrontera AG DPO Ratio 2011-2026 | BFRA
Annual DPO Ratio Biofrontera AG
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 168 | 314 | 148 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 314 | 148 | 210 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 9.13 | -0.76 % | $ 591 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.91 | 2.42 % | $ 6.69 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.47 | 1.19 % | $ 3.72 B | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.24 | 0.9 % | $ 62.5 M | ||
|
Galapagos NV
GLPG
|
81.9 | $ 28.07 | 0.75 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Harmony Biosciences Holdings
HRMY
|
28.9 | $ 31.01 | -0.13 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
19.5 | $ 8.44 | - | $ 76.2 M | ||
|
Immuron Limited
IMRN
|
597 | $ 0.83 | 3.44 % | $ 6.55 M | ||
|
Incyte Corporation
INCY
|
200 | $ 98.87 | -0.23 % | $ 19.3 B | ||
|
InMed Pharmaceuticals
INM
|
129 | $ 0.71 | 1.28 % | $ 1.74 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Jaguar Health
JAGX
|
676 | $ 7.55 | -4.13 % | $ 17.6 M | ||
|
KalVista Pharmaceuticals
KALV
|
1.03 K | $ 26.67 | -0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
106 | $ 8.15 | 0.49 % | $ 260 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 223.98 | -0.39 % | $ 4.1 B | ||
|
Liquidia Corporation
LQDA
|
209 | $ 38.39 | 0.62 % | $ 3.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.08 | 0.74 % | $ 436 M |